OKYONasdaqBiological Products, (No Diagnostic Substances)
OKYO Pharma Ltd
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026
$1.40−0.01 (-0.71%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Community
Notes and questions about OKYO Pharma from other investors
No posts about OKYO yet
Discussion opens with sign-in. Posts will be able to point at any number on these pages, so everyone sees exactly which figure is being discussed.